Medigen Vaccine Biologics Corporation (TPEX: 6547)

Medigen Vaccine Biologics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	544.35	1,393	1,204	1,380	1,679	410.62
Short-Term Investments	1,217	2,364	2,980	800	-	-
Trading Asset Securities	-	-	52.99	53.1	53.17	53.23
Cash & Short-Term Investments	1,761	3,757	4,237	2,233	1,733	463.85
Cash Growth	-52.84%	-11.33%	89.77%	28.87%	273.52%	-35.54%
Accounts Receivable	255.49	149.11	194.4	640.19	4.46	-
Other Receivables	13.85	49.74	1.17	0.07	126.25	-
Receivables	269.34	198.84	195.57	640.26	130.72	-
Inventory	433.38	386.47	903.4	610.84	77.43	8.4
Prepaid Expenses	18.47	10.66	12.37	32.29	17.3	2.9
Other Current Assets	54.05	48.14	113.89	205.07	51.64	43.79
Total Current Assets	2,536	4,401	5,462	3,721	2,010	518.93
Property, Plant & Equipment	1,329	1,385	1,470	1,414	1,343	1,663
Long-Term Investments	403.93	246.13	263.56	54	-	-
Other Intangible Assets	31.06	38.3	45.36	52.98	60.01	61.81
Other Long-Term Assets	16.18	22.36	106.83	57.26	77.71	33.28
Total Assets	4,316	6,093	7,348	5,299	3,491	2,277
Accounts Payable	4.61	25.89	109.1	88.53	21.78	34.32
Short-Term Debt	-	-	-	-	-	30
Current Portion of Long-Term Debt	23.05	1,708	-	-	-	77.08
Current Portion of Leases	11.54	12	11.78	1.99	1.93	8.36
Current Unearned Revenue	-	-	-	111.41	-	-
Other Current Liabilities	160.69	245.73	234.35	237.15	137.27	78.07
Total Current Liabilities	199.89	1,992	355.23	439.09	160.98	227.83
Long-Term Debt	-	-	1,678	-	-	356.09
Long-Term Leases	256.99	254.36	266.35	183.87	185.85	326.37
Other Long-Term Liabilities	-	-	19.25	-	2.58	-
Total Liabilities	456.88	2,246	2,319	622.95	349.4	910.28
Common Stock	3,287	3,286	3,278	2,129	2,111	1,560
Additional Paid-In Capital	398.59	1,551	2,798	1,135	2,319	294.58
Retained Earnings	83.13	-1,018	-1,132	1,410	-1,292	-617.72
Comprehensive Income & Other	90.34	27.85	84.03	1.92	3.27	129.67
Shareholders' Equity	3,859	3,847	5,029	4,676	3,141	1,367
Total Liabilities & Equity	4,316	6,093	7,348	5,299	3,491	2,277
Total Debt	291.57	1,974	1,956	185.85	187.78	797.89
Net Cash (Debt)	1,469	1,783	2,281	2,047	1,545	-334.04
Net Cash Growth	-16.72%	-21.85%	11.45%	32.50%	-	-
Net Cash Per Share	4.52	5.43	7.05	6.37	5.57	-1.45
Filing Date Shares Outstanding	315.29	328.61	327.84	315.67	313.02	231.36
Total Common Shares Outstanding	315.29	328.61	327.84	315.67	313.02	231.36
Working Capital	2,336	2,410	5,107	3,282	1,849	291.1
Book Value Per Share	12.24	11.71	15.34	14.81	10.04	5.91
Tangible Book Value	3,828	3,808	4,984	4,623	3,081	1,305
Tangible Book Value Per Share	12.14	11.59	15.20	14.65	9.84	5.64
Buildings	-	1,130	1,127	1,121	1,117	1,117
Machinery	-	650.64	626.59	570.9	388.46	383.4
Construction In Progress	-	21.37	14.54	4.7	17.54	100
Leasehold Improvements	-	3.34	3.03	2.55	1.89	1.89

Source: S&P Capital IQ. Standard template. Financial Sources.